Innovent Biologics Inc
HKEX:1801
Innovent Biologics Inc
Tax Provision
Innovent Biologics Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Innovent Biologics Inc
HKEX:1801
|
Tax Provision
¥116.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Tax Provision
-¥507.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Tax Provision
-¥146.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Tax Provision
-¥449.9m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-29%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Tax Provision
-¥1.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-48%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Tax Provision
-¥220.7m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
See Also
What is Innovent Biologics Inc's Tax Provision?
Tax Provision
116.5m
CNY
Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Tax Provision amounts to 116.5m CNY.